HLA class II neoantigen presentation for CD4 <sup>+</sup> T cell surveillance in HLA class II-negative colorectal cancerSatoru Matsumoto(Tohoku University), Toshihiko Torigoe(Sapporo Medical University)OncoImmunologySeptember 19, 202410.1080/2162402x.2024.2404665Cited by 5SaveCiteExport RISWatch citationsRelated PapersProteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue|JCI Insight|2021|33Cisplatin‐induced <scp>HSF1‐HSP90</scp> axis enhances the expression of functional <scp>PD‐L1</scp> in oral squamous cell carcinoma|Cancer Medicine|2022|23